title: Thrombosis during the use of the heparinoid Organon 10172 in a patient with heparin-induced thrombocytopenia.
authors.affiliation: Department of Cardiothoracic Anesthesia, Cleveland Clinic Foundation, Ohio 44195, USA.
authors.forename: S R
authors.initials: SR
authors.lastname: Insler
authors.forename: E J
authors.initials: EJ
authors.lastname: Kraenzler
authors.forename: J R
authors.initials: JR
authors.lastname: Bartholomew
authors.forename: K
authors.initials: K
authors.lastname: Kottke-Marchant
authors.forename: B
authors.initials: B
authors.lastname: Lytle
authors.forename: N J
authors.initials: NJ
authors.lastname: Starr
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D002809:Chondroitin Sulfates / Q000009:adverse effects*; D003871:Dermatan Sulfate / Q000009:adverse effects*; D006493:Heparin / Q000009:adverse effects*; D006497:Heparan Sulfate / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013921:Thrombocytopenia / Q000139:chemically induced*; D013927:Thrombosis / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D006493:Heparin; D006497:Heparan Sulfate; C035838:danaparoid